NovImmune raised €17M in a Series D+ round in Dec 2010. The company is based in Plan-les-Ouates, Switzerland. Investors in the round: BZ Bank. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
